Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The data of patients undergoing bronchoscopic volume reduction procedure will be analyzed retrospectively. Patients will be divided into two groups as patients with and without Pulmonary Rehabilitation before the procedure, and changes in functional levels of patients will be compared.
The data of patients who underwent bronchoscopic volume reduction between January 2013 and March 2019 will be examined.
Patients will be divided into two groups as pulmonary rehabilitation applied (PR group) and not applied (Control group) before the procedure.
Changes in the parameters of initial and rehabilitation follow-up will be examined.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pulmonary Rehabilitation Group | Experimental | Optimal medication and clinical follow-up plus Pulmonary rehabiltation |
|
| Non-Pulmonary Rehabilitation Group | Active Comparator | Optimal medication and clinical follow-up |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pulmonary Rehabilitation | Other | Exercise training+ Optimal medication and clinical follow-up |
|
| Measure | Description | Time Frame |
|---|---|---|
| Six minute walking test | The test was conducted in a 30-meter corridor in line with American Thoracic Society (ATS) guidelines. Patients were asked to walk as far as they can. Prior to and following the test, oxygen saturation, heart rate and Borg fatigue rating were measured, and the walking distance were recorded | 20 minutes |
| Pulmonary Function Tests | PFTs were performed by using the Sensormedics model 2400 (Yorba Linda, CA, USA) spirometry device, and according to the American Thoracic Society (ATS) guidelines | 15 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| Carbonmonoxide diffusion test | It will performed in the pulmonary function test laboratory using Cosmed Quark PFT (USA) with single-breath technique | 15 minutes |
Not provided
Inclusion Criteria:
Exclusion Criteria:
• Patients who develop complications related to the procedure after bronchoscopic procedure.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D004646 | Emphysema |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Standart care | Other | Optimal medication and clinical follow-up |
|